Nothing Special   »   [go: up one dir, main page]

FR21C1005I2 - STREPTOCOCCUS PYOGENES ANTIGENS AND CORRESPONDING DNA FRAGMENTS - Google Patents

STREPTOCOCCUS PYOGENES ANTIGENS AND CORRESPONDING DNA FRAGMENTS

Info

Publication number
FR21C1005I2
FR21C1005I2 FR21C1005C FR21C1005C FR21C1005I2 FR 21C1005 I2 FR21C1005 I2 FR 21C1005I2 FR 21C1005 C FR21C1005 C FR 21C1005C FR 21C1005 C FR21C1005 C FR 21C1005C FR 21C1005 I2 FR21C1005 I2 FR 21C1005I2
Authority
FR
France
Prior art keywords
streptococcus pyogenes
dna fragments
corresponding dna
antigens
pyogenes antigens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR21C1005C
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ID BIOMEDICAL CORP
Original Assignee
ID BIOMEDICAL CORP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ID BIOMEDICAL CORP filed Critical ID BIOMEDICAL CORP
Publication of FR21C1005I1 publication Critical patent/FR21C1005I1/fr
Application granted granted Critical
Publication of FR21C1005I2 publication Critical patent/FR21C1005I2/en
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0208—Specific bacteria not otherwise provided for
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56944—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/315—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Streptococcus (G), e.g. Enterococci
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Otolaryngology (AREA)
  • Toxicology (AREA)

Abstract

The present invention relates to antigens more particularly antigens of Streptococcus pyogenes (also called group A Streptococcus (GAS)) bacterial pathogen which are useful as vaccine component for therapy and/or prophylaxis.
FR21C1005C 2000-12-21 2021-02-04 STREPTOCOCCUS PYOGENES ANTIGENS AND CORRESPONDING DNA FRAGMENTS Active FR21C1005I2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25694000P 2000-12-21 2000-12-21
PCT/CA2001/001853 WO2002050107A2 (en) 2000-12-21 2001-12-21 Streptococcus pyogenes antigens and corresponding dna fragments

Publications (2)

Publication Number Publication Date
FR21C1005I1 FR21C1005I1 (en) 2021-03-26
FR21C1005I2 true FR21C1005I2 (en) 2022-01-14

Family

ID=22974225

Family Applications (1)

Application Number Title Priority Date Filing Date
FR21C1005C Active FR21C1005I2 (en) 2000-12-21 2021-02-04 STREPTOCOCCUS PYOGENES ANTIGENS AND CORRESPONDING DNA FRAGMENTS

Country Status (12)

Country Link
US (5) US7595057B2 (en)
EP (1) EP1343895B1 (en)
JP (1) JP4080876B2 (en)
AT (1) ATE398677T1 (en)
AU (2) AU2002216863B8 (en)
BE (1) BE2021C506I2 (en)
BR (1) BR0116704A (en)
CA (2) CA2432525C (en)
DE (1) DE60134494D1 (en)
ES (1) ES2307564T3 (en)
FR (1) FR21C1005I2 (en)
WO (1) WO2002050107A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1343895B1 (en) * 2000-12-21 2008-06-18 ID Biomedical Corporation Streptococcus pyogenes antigens and corresponding dna fragments
GB0130228D0 (en) 2001-12-18 2002-02-06 Hansa Medica Ab Protein
CA2535863A1 (en) * 2003-08-15 2005-02-24 Id Biomedical Corporation Polypeptides of streptococcus pyogenes
GB201502305D0 (en) 2015-02-12 2015-04-01 Hansa Medical Ab Protein
GB201502306D0 (en) 2015-02-12 2015-04-01 Hansa Medical Ab Protein

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5854416A (en) * 1991-11-14 1998-12-29 The United States Of America As Represented By The Department Of Health And Human Services Streptococcus pneumoniae 37-KDA surface adhesin a protein and nucleic acids coding therefor
US6287574B1 (en) 1995-03-17 2001-09-11 Biochem Pharma Inc. Proteinase K resistant surface protein of neisseria meningitidis
TR200002437T2 (en) * 1998-02-20 2000-11-21 Biochem Pharma Inc. Group B streptococcus antigens.
GB9807890D0 (en) * 1998-04-09 1998-06-10 Actinova Ltd Peptides
WO2000006736A2 (en) 1998-07-27 2000-02-10 Microbial Technics Limited Nucleic acids and proteins from group b streptococcus
EP1100921B1 (en) 1998-07-27 2007-05-02 Sanofi Pasteur Limited Streptococcus pneumoniae proteins and nucleic acid molecules
US7128918B1 (en) * 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
GB9828880D0 (en) * 1998-12-31 1999-02-17 Actinova Ltd Protein
US7074415B2 (en) * 2000-06-20 2006-07-11 Id Biomedical Corporation Streptococcus antigens
JP4718099B2 (en) * 2000-07-06 2011-07-06 アイディー バイオメディカル コーポレイション Streptococcus pyogens antigen
AU2002210301A1 (en) * 2000-10-13 2002-04-22 Shire Biochem Inc. Bvh-a2 and bvh-a3 antigens of group b streptococcus
EP1671981A3 (en) * 2000-10-27 2006-07-05 Chiron SRL. Nucleic acids and proteins from streptococcus group A
EP1343895B1 (en) * 2000-12-21 2008-06-18 ID Biomedical Corporation Streptococcus pyogenes antigens and corresponding dna fragments
JP4281861B2 (en) * 2001-02-21 2009-06-17 アイディ・バイオメディカル・コーポレイション STREPTOCOCCUS PYOGENES polypeptides and corresponding DNA fragments
BR0208874A (en) * 2001-04-13 2004-06-22 Wyeth Corp Surface proteins of streptococcus pyogenes
BR0210875A (en) * 2001-07-06 2004-06-22 Shire Biochem Inc Group b streptococcus antigens and corresponding DNA fragments
GB0130228D0 (en) * 2001-12-18 2002-02-06 Hansa Medica Ab Protein
US7262024B2 (en) * 2001-12-20 2007-08-28 Id Biomedical Corporation Streptococcus antigens
WO2004007725A1 (en) * 2002-07-15 2004-01-22 Id Biomedical Corporation Polypeptide of streptococcus pyogenes
CA2535863A1 (en) * 2003-08-15 2005-02-24 Id Biomedical Corporation Polypeptides of streptococcus pyogenes
JP2008544949A (en) * 2004-10-08 2008-12-11 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド Immunostimulatory and therapeutic compositions for pyogenic streptococci
ATE548049T1 (en) * 2005-06-09 2012-03-15 Hansa Medical Ab USE OF IDES PROTEINASE (FROM S. PYOGENES) TO TREAT AUTOIMMUNE DISEASES AND TRANSPLANT REJECTION
US8309096B2 (en) * 2007-01-15 2012-11-13 Glaxosmithkline Biologicals S.A. Fusion protein
JP5722627B2 (en) * 2007-09-14 2015-05-27 ジェノビス エービー Methods and kits for dissociation of FC gamma receptor-IgG complex and purification and detection of IgG
GB201003920D0 (en) * 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Method of treatment
GB201115841D0 (en) * 2011-09-13 2011-10-26 Genovis Ab Protein and method
GB201316744D0 (en) * 2013-09-20 2013-11-06 Genovis Ab Method
GB201416849D0 (en) * 2014-09-24 2014-11-05 Genovis Ab Method

Also Published As

Publication number Publication date
AU2002216863B2 (en) 2008-02-28
AU1686302A (en) 2002-07-01
CA2432525C (en) 2012-11-27
US8821895B2 (en) 2014-09-02
US20150017684A1 (en) 2015-01-15
DE60134494D1 (en) 2008-07-31
WO2002050107A3 (en) 2003-04-10
US9340586B2 (en) 2016-05-17
AU2002216863B8 (en) 2008-03-20
ATE398677T1 (en) 2008-07-15
US7595057B2 (en) 2009-09-29
BE2021C506I2 (en) 2021-05-31
BR0116704A (en) 2003-12-23
US8298551B2 (en) 2012-10-30
EP1343895A2 (en) 2003-09-17
WO2002050107A2 (en) 2002-06-27
CA2432525A1 (en) 2002-06-27
US20130136760A1 (en) 2013-05-30
CA2789252C (en) 2016-11-15
FR21C1005I1 (en) 2021-03-26
US20100119507A1 (en) 2010-05-13
JP2004524014A (en) 2004-08-12
ES2307564T3 (en) 2008-12-01
JP4080876B2 (en) 2008-04-23
CA2789252A1 (en) 2002-06-27
ES2307564T9 (en) 2021-04-26
US20040097706A1 (en) 2004-05-20
US20160326221A1 (en) 2016-11-10
EP1343895B1 (en) 2008-06-18

Similar Documents

Publication Publication Date Title
FR21C1005I2 (en) STREPTOCOCCUS PYOGENES ANTIGENS AND CORRESPONDING DNA FRAGMENTS
CY1118443T1 (en) ANTI-TNF ANTIBODIES, COMPOSITIONS, METHODS AND USES
NZ524888A (en) Nucleic acids and proteins from streptococcus groups A & B
MY125202A (en) Vaccine
ATE412750T1 (en) ANTIGEN FROM STREPTOCOCCUS PYOGENES
WO2004043407A3 (en) Methods and products for treating staphylococcal infections
DE60125797D1 (en) IMPFSTOFFZUSAMMESETZUNG
IL196900A (en) Autologous t-cell vaccine compositions
CY1117746T1 (en) Influenza hematopoietic antigens and corresponding DNA fragments
NO20030407D0 (en) Silicate-mediated synthesis of immorphous silicates and siloxanes and their use
WO2002060917A3 (en) Method to treat hemophilia
YU68602A (en) Monoclonal antibodies to the human ldl receptor, their production and use
ATE456659T1 (en) STREPTOCOCCUS PYOGENES POLYPEPTIDES AND CORRESPONDING DNA FRAGMENTS
ATE349531T1 (en) ISOLATION AND CHARACTERIZATION OF THE CSA OPERON (ETEC-CS4 PILI) AND METHOD OF ITS APPLICATION
IL156799A0 (en) Peptides having affinity for the gp120 viral protein and use thereof
BR0111785A (en) Compositions and methods for treating candidiasis
DE60234772D1 (en) GROUP-B STREPTOCOCCUS ANTIGENIC AND CORRESPONDING DNA FRAGMENTS
DK0792347T3 (en) Methods for Preparation of Enhanced Antigenic Heliobacter sp. and vaccines comprising the same
WO2001064840A8 (en) Novel bone marrow nucleic acids and polypeptides
AU6709500A (en) Trehalose producing cells as vaccines
SG166673A1 (en) Immunostimulatory nucleic acids
MY155265A (en) Anti-dual integrin antibodies, compositions, methods and uses